1. Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited.
J Am Soc Nephrol 2004;15:241–250.
2. Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Kidney Int 2004;65:521–530.
3. Wilhelmus S, Alpers CE, Cook HT, et al. The revisited classification of GN in SLE at 10 years: time to re-evaluate histopathologic lesions.
J Am Soc Nephrol 2015;26:2938–2946.
4. Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.
Kidney Int 2018;93:789–796.
5. Decker JL, Steinberg AD, Reinertsen JL, Plotz PH, Balow JE, Klippel JH. NIH conference: systemic lupus erythematosus: evolving concepts.
Ann Intern Med 1979;91:587–604.
6. Austin HA 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data.
Am J Med 1983;75:382–391.
7. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.
Kidney Int 1984;25:689–695.
8. Morel-Maroger L, Méry JP, Droz D, et al. The course of lupus nephritis: contribution of serial renal biopsies.
Adv Nephrol Necker Hosp 1976;6:79–118.
9. Leaker B, Fairley KF, Dowling J, Kincaid-Smith P. Lupus nephritis: clinical and pathological correlation.
Q J Med 1987;62:163–179.
10. Magil AB, Puterman ML, Ballon HS, et al. Prognostic factors in diffuse proliferative lupus glomerulonephritis.
Kidney Int 1988;34:511–517.
11. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.
Q J Med 1989;72:779–833.
12. Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy.
Q J Med 1991;81:907–918.
13. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP. The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy.
Semin Arthritis Rheum 1993;23:135–148.
14. Esdaile JM, Abrahamowicz M, MacKenzie T, Hayslett JP, Kashgarian M. The time-dependence of long-term prediction in lupus nephritis.
Arthritis Rheum 1994;37:359–368.
15. Jennette JC, Heptinstall RH. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
16. D’Agati VD, Jennette JC, Silva FG. Atlas of nontumor pathology: non-neoplastic kidney diseases. Washington, DC: American Registry of Pathology; 2005.
17. Fogo AB, Kashgarian M. Diagnostic atlas of renal pathology. 3rd ed. Philadelphia: Elsevier; 2017.
18. Colvin RB, Chang A. Diagnostic pathology: kidney diseases. 3rd ed. Philadelphia: Elsevier; 2019.
19. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data.
Kidney Int 1994;45:544–550.
20. Arce-Salinas CA, Villa AR, Martínez-Rueda JO, et al. Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study.
Lupus 1995;4:197–203.
21. Yokoyama H, Wada T, Hara A, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.
Kidney Int 2004;66:2382–2388.
22. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization.
Am J Med 1987;83:877–885.
23. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group.
Kidney Int 1992;42:743–748.
24. Levey AS, Lan SP, Corwin HL, et al. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study: results of treatment with prednisone and short-term oral cyclophosphamide.
Ann Intern Med 1992;116:114–123.
25. Wu LH, Yu F, Tan Y, et al. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions.
Kidney Int 2013;83:715–723.
26. Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.
Arthritis Care Res (Hoboken) 2011;63:865–874.
27. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group.
Am J Kidney Dis 1993;21:374–377.
28. Dasari S, Chakraborty A, Truong L, Mohan C. A systematic review of interpathologist agreement in histologic classification of lupus nephritis.
Kidney Int Rep 2019;4:1420–1425.
29. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.
Kidney Int 2009;76:546–556.
30. Jia Q, Ma F, Yang X, et al. Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria.
Clin Exp Nephrol 2022;26:257–265.
31. Rijnink EC, Teng YK, Wilhelmus S, et al. Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis.
Clin J Am Soc Nephrol 2017;12:734–743.
32. Obrișcă B, Jurubiță R, Andronesi A, et al. Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.
Lupus 2018;27:1455–1463.
33. Tao J, Wang H, Yu XJ, et al. A validation of the 2018 revision of International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: a cohort study from China.
Am J Nephrol 2020;51:483–492.
35. Nakagawa S, Toyama T, Iwata Y, et al. The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: a retrospective single-center study.
Lupus 2021;30:1739–1746.
36. Krassanairawiwong K, Charoenpitakchai M, Supasyndh O, Satirapoj B. Revised ISN/RPS 2018 classification of lupus renal pathology predict clinical remission.
Int Urol Nephrol 2021;53:1391–1398.
37. Navarro D, Ferreira AC, Viana H, Carvalho F, Nolasco F. Morphological indexes: can they predict lupus nephritis outcomes?: a retrospective study.
Acta Med Port 2019;32:635–640.
39. Hill GS, Delahousse M, Nochy D, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
Kidney Int 2000;58:1160–1173.
40. Rathi M, Gupta KL, Joshi K, et al. Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices.
Rheumatol Int 2015;35:1511–1517.